Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China

被引:44
|
作者
Wang, Jiao [1 ]
Chen, Rong-Ping [1 ]
Lei, Lei [1 ]
Song, Qing-Qing [1 ]
Zhang, Ru-Yi [1 ]
Li, Yan-Bing [2 ]
Yang, Chuan [3 ]
Lin, Shao-Da [4 ]
Chen, Li-shu [5 ]
Wang, Yu-Lin [6 ]
Zhao, Fan [7 ]
Liang, Gan-Xiong [8 ]
Hu, Bao-Chun [9 ]
Lin, Jian-Cai [10 ]
Cai, De-Hong [1 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou 510282, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China
[4] Shantou Univ, Coll Med, Dept Endocrinol, Affiliated Hosp 1, Shantou, Peoples R China
[5] Shantou Univ, Coll Med, Dept Endocrinol, Affiliated Hosp 2, Shantou, Peoples R China
[6] Peopls Hosp Shenzhen, Dept Endocrinol, Shenzhen, Peoples R China
[7] Peoples Hosp Jiangmen, Dept Endocrinol, Jiangmen, Peoples R China
[8] Zhongshan Peoples Hosp, Dept Endocrinol, Zhongshan, Peoples R China
[9] Wu Jing Zong Dui Hosp Guangdong Prov, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China
[10] Jiangmen Cent Hosp, Dept Endocrinol, Jiangmen, Peoples R China
关键词
prevalence; risk factors; hyperuricemia; type 2 diabetes mellitus; central obesity; SERUM URIC-ACID; CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; METABOLIC SYNDROME; ALL-CAUSE; POPULATION; MORTALITY; LEVEL; WOMEN;
D O I
10.6133/apjcn.2013.22.4.16
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This study investigated the prevalence and determinants of hyperuricemia in Chinese type 2 diabetes mellitus (T2DM) patients with central obesity. A multicentric hospital-based cross-sectional study was carried out in Guangdong Province between August 2011 and March 2012. At each hospital, Chinese T2DM patients with central obesity who were aged over 20 years, whose serum uric acid levels were measured, and who had lived in Guangdong Province for >= 1 year, were recruited. Hyperuricemia was defined as serum uric acid >420 mu mol/L in men and >360 mu mol/L in women. Binary logistic regression was used to assess associated risk factors for hyperuricemia. A total of 2,917 T2DM patients with central obesity took part. The overall prevalence of hyperuricemia was 32.6% (36.1% for women, 28.4% for men). Binary logistic regression analyses demonstrated that women (OR: 1.576; 95% confidence interval (CI): 1.231, 2.018), high BMI (OR: 1.228; 95% CI: 1.094, 1.379), waist circumference (OR: 1.135; 95% CI: 1.009, 1.276), hypertension (OR: 1.603; 95% CI: 1.263, 2.035), high total cholesterol (OR: 1.133; 95% CI: 1.002, 1.281), triglycerides (OR: 1.134; 95% CI: 1.069, 1.203), low HDL-cholesterol (OR: 0.820; 95% CI: 0.677, 0.995) and low estimated glomerular filtration rate (OR: 0.840; 95% CI: 0.815, 0.866) were risk factors associated with hyperuricemia. Hyperuricemia is prevalent in Chinese T2DM patients with central obesity and is significantly positively associated with women, cardiovascular risk factors such as obesity, hypertension and dyslipidemia, and low eGFR.
引用
收藏
页码:590 / 598
页数:9
相关论文
共 50 条
  • [21] The Prevalence and Control of Type 2 Diabetes Mellitus in Residents of a Rural Town, Shandong Province, China
    Wei, Maoti
    Dong, Li
    Wang, Fenghua
    Cui, Kai
    Ma, Delong
    Yang, Ning
    Li, Yuming
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 4505 - 4512
  • [22] Clinical analysis of prevalence of hyperuricemia and its correlation with cardiovascular complications in patients with type 2 Diabetes Mellitus
    Liu, X. L.
    Jiang, C. X.
    Xu, P.
    Yang, L. N.
    Liu, Q.
    Li, L. T.
    Wang, L.
    Zhang, T.
    Tian, Y. J.
    Hu, Y. Q.
    Han, F.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (02): : 7 - 13
  • [23] Central obesity, metabolic syndrome and type 2 diabetes mellitus
    Pusparini
    [J]. UNIVERSA MEDICINA, 2007, 26 (04) : 195 - 204
  • [24] Determinants of hypomagnesemia in patients with type 2 diabetes mellitus
    Kurstjens, Steef
    de Baaij, Jeroen H. F.
    Bouras, Hacene
    Bindels, Rene J. M.
    Tack, Cees J. J.
    Hoenderop, Joost G. J.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 176 (01) : 11 - 19
  • [25] Management of Obesity in Patients with Type 2 Diabetes Mellitus
    Gagliardi, Lucia
    Witterti, Gary
    [J]. CURRENT DIABETES REVIEWS, 2007, 3 (02) : 95 - 101
  • [26] Prevalence of hyperuricemia among type 2 diabetes mellitus patients in Africa: a systematic review and meta-analysis
    Ermiyas Alemayehu
    Temesgen Fiseha
    Getachew Mesfin Bambo
    Samuel Sahile Kebede
    Habtye Bisetegn
    Mihret Tilahun
    Habtu Debash
    Hussen Ebrahim
    Ousman Mohammed
    Melaku Ashagrie Belete
    Alemu Gedefie
    [J]. BMC Endocrine Disorders, 23
  • [27] Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population
    Sofia Tsirona
    Fotis Katsaros
    Alexandra Bargiota
    Stergios A. Polyzos
    George Arapoglou
    George N. Koukoulis
    [J]. Hormones, 2016, 15 : 88 - 98
  • [28] The prevalence of albuminuria among patients with type 2 diabetes mellitus in Central Anatolia, Turkey
    Kelestimur, F
    Emeklioglu, S
    Utas, C
    Unluhizarci, K
    Bayram, F
    [J]. DIABETOLOGIA, 1997, 40 : 2066 - 2066
  • [29] Prevalence and determinants of type 2 diabetes mellitus in a Greek adult population
    Tsirona, Sofia
    Katsaros, Fotis
    Bargiota, Alexandra
    Polyzos, Stergios A.
    Arapoglou, George
    Koukoulis, George N.
    [J]. HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 15 (01): : 88 - 98
  • [30] Prevalence of hyperuricemia among type 2 diabetes mellitus patients in Africa: a systematic review and meta-analysis
    Alemayehu, Ermiyas
    Fiseha, Temesgen
    Bambo, Getachew Mesfin
    Kebede, Samuel Sahile
    Bisetegn, Habtye
    Tilahun, Mihret
    Debash, Habtu
    Ebrahim, Hussen
    Mohammed, Ousman
    Belete, Melaku Ashagrie
    Gedefie, Alemu
    [J]. BMC ENDOCRINE DISORDERS, 2023, 23 (01)